Jiangxi Aicare Medical Technology Co.,Ltd

Jiangxi AICARE Medical Technology Co., Ltd. is a wholly-owned subsidiary of AICARE wisdom medical. The Company has been intensively engaged in the management of chronic diseases such as diabetes and hypertension for a long time, and the Company is committed to the research and development of intelligent medical devices such as blood glucose meter and sphygmomanometer and the development of cloud-based chronic disease management system, and is the leading provider for "internet +" chronic disease management solution and operation service in China. Up to now, the Company has more than 60 technical patents, of which many products have passed CFDA certification and CE certification, and continuously serves more than 200 large medical institutions such as Xiangya Hospital Central South University. The platform has served more than 300,000 patients with chronic diseases such as diabetes and hypertension. During the novel coronavirus epidemic, AICARE wisdom medical responded to the government's call actively, shouldered social responsibilities bravely, and added 10 mask production lines and 8 thermometer production lines urgently to produce epidemic prevention materials, so AICARE becomes the national key guarantee enterprise for epidemic prevention and control. The production line has realized a daily output of 1 million disposable medical masks and surgical masks and 50,000 sets of thermometer, respectively, ranking among the top three in the country, and AICARE has made an important contribution to ensure the supply of epidemic prevention materials. In terms of product quality, the above two types of protective articles have obtained authorized certifications such as national medical device registration certificate, production license, CE certificate, FDA certificate, etc. During the epidemic, AICARE wisdom medical has provided a large number of materials to the epidemic prevention headquarters of the State Council and the headquarters of Jiangxi Province, and the epidemic prevention materials are exported overseas to projectChinese powerto global epidemic continuously. In the future, the Company will continue to explore and practice the innovative service modes of chronic disease management, so that every patient with chronic disease can enjoy the medical services within reach, and the Company is committed to becoming an influential and intelligent chronic disease management industry in China. At the same time, the Company will enhance the research and development productivity of new medical protective equipment and make greater efforts to improve residents' epidemic prevention ability and protect residents' health.